News tagged with patents
FDA denies request to block generic painkiller
In a surprise move, federal health regulators have denied a request by Endo Health Solutions to block generic versions of its painkiller Opana ER, which the company argued can be more easily abused than its branded product.
Medications
May 10, 2013 |
not rated yet |
0
Lundbeck profit jumps but warns on generic pressure
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
Medications
May 01, 2013 |
not rated yet |
0
Research suggests transmission of respiratory viruses in utero
The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's ...
Diseases, Conditions, Syndromes
Apr 18, 2013 |
not rated yet |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
Physician entrepreneurs are key contributors to new medical devices
Startup companies founded by physician entrepreneurs are an important source of patents used in developing innovative new medical devices, suggests a study in the May issue of Medical Care. ...
Other
Apr 16, 2013 |
5 / 5 (1) |
0
Patenting genes: Justices tackle big health issue (Update 2)
The Supreme Court seemed worried Monday about the idea of companies patenting human genes in a case that could profoundly reshape the multibillion-dollar biomedical industry and U.S. research in the fight ...
Genetics
Apr 15, 2013 |
5 / 5 (2) |
1
Court: Can human genes be patented? (Update)
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian ...
Genetics
Apr 15, 2013 |
5 / 5 (1) |
1
US top court to hear case on gene patents
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics
Apr 13, 2013 |
5 / 5 (2) |
0
Are human genes patentable?
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics
Apr 11, 2013 |
4.3 / 5 (6) |
16
|
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications
Apr 10, 2013 |
5 / 5 (1) |
0
|
Probe to detect spread of breast cancer gets distribution boost
A device co-developed by a University of Houston (UH) physicist to detect the spread of breast cancer and allow physicians to better plan intervention is extending its market reach, bringing it another step ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Court overturns $482M patent decision against J&J
(AP)—A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.
Other
Apr 04, 2013 |
not rated yet |
0
Cells culled from adults may grow human bone
Preparations are underway for the first known human trial to use embryonic-like stem cells collected from adult cells to grow bone.
Medical research
Apr 02, 2013 |
5 / 5 (1) |
0
|
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
India's top court to deliver Novartis judgment
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies ...
Medications
Mar 31, 2013 |
not rated yet |
0
Patent
A patent ( /ˈpætənt/ or /ˈpeɪtənt/) is a form of intellectual property. It consists of a set of exclusive rights granted by a sovereign state to an inventor or their assignee for a limited period of time in exchange for the public disclosure of an invention.
The procedure for granting patents, the requirements placed on the patentee, and the extent of the exclusive rights vary widely between countries according to national laws and international agreements. Typically, however, a patent application must include one or more claims defining the invention which must meet the relevant patentability requirements such as novelty and non-obviousness. The exclusive right granted to a patentee in most countries is the right to prevent others from making, using, selling, or distributing the patented invention without permission.
Under the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights, patents should be available in WTO member states for any inventions, in all fields of technology, and the term of protection available should be a minimum of twenty years. In many countries, certain subject areas are excluded from patents, such as business methods and computer programs.
For more information about Patent, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
